Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy

被引:0
|
作者
Katsuyama, Eri [1 ]
Wakabayashi, Hiroshi [2 ]
Sada, Ken-ei [1 ]
Hiramatsu, Sumie [1 ]
Miyawaki, Yoshia [1 ]
Morishita, Michiko [1 ]
Ohashi, Keiji [1 ]
Watanabe, Haruki [1 ]
Katsuyama, Takayuki [1 ]
Zeggar, Sonia [1 ]
Narazaki, Mariko [1 ]
Tatebe, Noriko [1 ]
Watanabe, Katsue S. [1 ]
Kawabata, Tomoko [1 ]
Wada, Jun [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama 7008558, Japan
[2] Okayama Municipal Hosp, Okayama 7000962, Japan
关键词
ankylosing spondylitis; rituximab; treatment; OPEN-LABEL; INFLIXIMAB; TRIAL; INFLAMMATION; ABATACEPT;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.
引用
收藏
页码:445 / 448
页数:4
相关论文
共 50 条
  • [21] Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF
    Boyraz, Ismail
    Koc, Bunyamin
    Boyaci, Ahmet
    Tutoglu, Ahmet
    Sarman, Hakan
    Ozkan, Hilal
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (09): : 2912 - 2915
  • [22] Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register
    Lord, Paul A. C.
    Farragher, Tracey M.
    Lunt, Mark
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2010, 49 (03) : 563 - 570
  • [23] A prospective clinical investigation of the effects of anti-TNF alpha therapy on exercise capacity in patients with ankylosing spondylitis
    Capkin, Erhan
    Keskin, Seyhan Bilge
    Karkucak, Murat
    Ayar, Ahmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (01) : 27 - 32
  • [24] Lichen planus under anti TNF therapy for ankylosing spondylitis
    Wendling, Daniel
    Biver-Dalle, Caroline
    Vidon, Claire
    Prati, Clement
    Aubin, Francois
    JOINT BONE SPINE, 2013, 80 (02) : 227 - 228
  • [25] Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study
    Kristensen, Lars E.
    Petersson, Ingemar F.
    Geborek, Pierre
    Joud, Anna
    Saxne, Tore
    Jacobsson, Lennart T. H.
    Englund, Martin
    RHEUMATOLOGY, 2012, 51 (02) : 243 - 249
  • [26] Circulating miR-145 as a Marker of Therapeutic Response to Anti-TNF Therapy in Patients With Ankylosing Spondylitis
    Prajzlerova, Klara
    Komarc, Martin
    Forejtova, Sarka
    Pavelka, Karel
    Vencovsky, Jiri
    Senolt, Ladislav
    Filkova, Maria
    PHYSIOLOGICAL RESEARCH, 2021, 70 (02) : 255 - 264
  • [27] Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNFα therapy: association with predictors of cardiovascular risk
    Maia, Diego Germano
    Augusto, Kristopherson Lustosa
    Bezerra, Mailze Campos
    Maia Rodrigues, Carlos Ewerton
    CLINICAL RHEUMATOLOGY, 2017, 36 (10) : 2371 - 2376
  • [28] Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy
    Genre, F.
    Lopez-Mejias, R.
    Miranda-Filloy, J. A.
    Ubilla, B.
    Carnero-Lopez, B.
    Gomez-Acebo, I.
    Blanco, R.
    Ochoa, R.
    Rueda-Gotor, J.
    Gonzalez-Juanatey, C.
    Llorca, J.
    Gonzalez-Gay, M. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : 218 - 224
  • [29] Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNFα therapy: association with predictors of cardiovascular risk
    Diego Germano Maia
    Kristopherson Lustosa Augusto
    Mailze Campos Bezerra
    Carlos Ewerton Maia Rodrigues
    Clinical Rheumatology, 2017, 36 : 2371 - 2376
  • [30] The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
    Karkucak, Murat
    Capkin, Erhan
    Alver, Ahmet
    Akyuz, Ayse
    Kiris, Abdulkadir
    Ak, Emel
    Topbas, Murat
    Tosun, Mehmet
    CLINICAL RHEUMATOLOGY, 2010, 29 (03) : 303 - 307